These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8863148)

  • 21. Women's views and experiences of two alternative consent pathways for participation in a preterm intrapartum trial: a qualitative study.
    Sawyer A; Chhoa C; Ayers S; Pushpa-Rajah A; Duley L
    Trials; 2017 Sep; 18(1):422. PubMed ID: 28886747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can unequal be more fair? Ethics, subject allocation, and randomised clinical trials.
    Avins AL
    J Med Ethics; 1998 Dec; 24(6):401-8. PubMed ID: 9873981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of two formats of informed consent on knowledge amongst persons with advanced HIV disease in a clinical trial of didanosine.
    Tindall B; Forde S; Ross MW; Goldstein D; Barker S; Cooper DA
    Patient Educ Couns; 1994 Dec; 24(3):261-6. PubMed ID: 7753719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using the Zelen design in randomized controlled trials: debates and controversies.
    Homer CS
    J Adv Nurs; 2002 Apr; 38(2):200-7. PubMed ID: 11940133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consent to clinical research--adequately voluntary or substantially influenced?
    Hewlett S
    J Med Ethics; 1996 Aug; 22(4):232-7. PubMed ID: 8863149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing two methods for delivering clinical trial informed consent information to older adults: singular versus stepped approach.
    O'Hare F; Flanagan Z; Nelson M; Curtis A; Heritier S; Spark S; Zoungas S
    Clin Trials; 2018 Dec; 15(6):610-615. PubMed ID: 30074410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SSPR Mini-Symposium: Methodologic Controversies in Clinical Research: Consent for experimentation involving neonates.
    Silverman WA
    Am J Med Sci; 1988 Nov; 296(5):354-9. PubMed ID: 3057915
    [No Abstract]   [Full Text] [Related]  

  • 29. How to do it. Get patients' consent to enter clinical trials.
    Wager E; Tooley PJ; Emanuel MB; Wood SF
    BMJ; 1995 Sep; 311(7007):734-7. PubMed ID: 7549691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The DiReCT study - improving recruitment into clinical trials: a mixed methods study investigating the ethical acceptability, feasibility and recruitment yield of the cohort multiple randomised controlled trials design.
    Richards DA; Ross S; Robens S; Borglin G
    Trials; 2014 Oct; 15():398. PubMed ID: 25318374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consent.
    Gillon R
    Br Med J (Clin Res Ed); 1985 Dec; 291(6510):1700-1. PubMed ID: 3935249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ethics of randomised controlled trials: a matter of statistical belief?
    Hutton JL
    Health Care Anal; 1996 May; 4(2):95-102. PubMed ID: 10162773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The therapeutic misconception, beneficence, and respect.
    Fried E
    Account Res; 2001; 8(4):331-48. PubMed ID: 12481794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Communication of randomization in childhood leukemia trials.
    Kodish E; Eder M; Noll RB; Ruccione K; Lange B; Angiolillo A; Pentz R; Zyzanski S; Siminoff LA; Drotar D
    JAMA; 2004 Jan; 291(4):470-5. PubMed ID: 14747504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicians' views and experiences of offering two alternative consent pathways for participation in a preterm intrapartum trial: a qualitative study.
    Chhoa CY; Sawyer A; Ayers S; Pushpa-Rajah A; Duley L
    Trials; 2017 Apr; 18(1):196. PubMed ID: 28446203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Informed consent in medical research. Doctors are arrogant to think they need to debate issue of patient consent.
    Bratt DE
    BMJ; 1997 May; 314(7092):1477. PubMed ID: 9167569
    [No Abstract]   [Full Text] [Related]  

  • 37. Does different information disclosure on placebo control affect blinding and trial outcomes? A case study of participant information leaflets of randomized placebo-controlled trials of acupuncture.
    Cheon S; Park HJ; Chae Y; Lee H
    BMC Med Res Methodol; 2018 Jan; 18(1):13. PubMed ID: 29347917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical trials in cancer: the role of surrogate patients in defining what constitutes an ethically acceptable clinical experiment.
    Mackillop WJ; Palmer MJ; O'Sullivan B; Ward GK; Steele R; Dotsikas G
    Br J Cancer; 1989 Mar; 59(3):388-95. PubMed ID: 2930704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should consent forms used in clinical trials be translated into the local dialects? A survey among past participants in rural Ghana.
    Baiden F; Akazili J; Chatio S; Achana FS; Oduro AR; Ravinetto R; Hodgson A
    Clin Trials; 2016 Apr; 13(2):234-9. PubMed ID: 26452387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testing an alternate informed consent process.
    Yates BC; Dodendorf D; Lane J; LaFramboise L; Pozehl B; Duncan K; Knodel K
    Nurs Res; 2009; 58(2):135-9. PubMed ID: 19289935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.